Schedule 13G ownership disclosure

Haemonetics Corp

Security class unavailable · CUSIP: 405024100

Event date: 2022-01-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,537,538
Percent of class
10.8300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-22-000016
Form type
SC 13G/A
Filer
HAEMONETICS CORP
CIK
CIK 313143
Filed
Feb 10, 2022
Reporting period
Jan 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub